Drug combination may treat most aggressive lung cancer
Thursday, February 11, 2016 - 16:10
in Health & Medicine
Stephen FellerMADRID, Feb. 11 (UPI) -- A combination of the drugs dasatinib and demcizumab stopped the growth of an aggressive form of lung cancer in mice and human tumor samples in a new study.